CEPHALOSPORINS
Ceftriaxone Sod
Cefazolin
Ceftiofer Sod
Cefotaxime
Cefoperazone
Ceftizoxime
Cefipime + Argenine
Cefprozil
other Cephalosporins
Ceftazidime
Cefuroxime Sod
DMF, CEP, USFDA SUPPORT AVAILABLE
INTERMEDIATES FOR EXPORTS
INTERMEDIATE |
CAS NO |
API/ END USE |
STATUS |
|
Ethyl 4-(1-methyl-5-nitro-1H-benzo[ |
3543-72-4 |
Bendamustine |
Commercial |
|
Ethyl4-(5-amino-1-methyl-1H- |
3543-73-5 |
Bendamustine |
lab Scale |
|
4-(5-amino-1-methyl-1H- |
1313020-26-6 |
Bendamustine |
lab Scale |
|
S-(+)-Methyl-(2-chlorophenyl)[ |
141109-19-5 |
Clopidogrel |
Commercial |
|
4-Guanidinobenzoic Acid |
16060-65-4 |
Camostat mesylate |
Under development |
|
4- Guanidinobenzoic Acid HCl |
42823-46-1 |
Camostat mesylate |
Under development |
|
4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2- |
59721-16-3 |
Camostat mesylate |
under development |
|
3,4-Dibenzyloxybenzaldehyde |
09-02-5447 |
Droxidopa |
Under development |
|
Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate |
212322-56-0 |
Dabigatran |
Commercial |
|
2-(4-Cyanophenylamino) Acetic Acid |
42288-26-6 |
Dabigatran |
Commercial |
|
Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H- |
211915-84-3 |
Dabigatran |
Commercial |
|
Ethyl 3-(2-(((4-carbamimidoylphenyl) |
429658-95-7 |
Dabigatran |
Commercial |
|
Ethyl 3-(((2-(((4-(((( hexyloxy)carbonyl)amino) |
211915-06-9 |
Dabigatran |
Lab scale |
|
2-(N-BOC)-Aminothiazole-5- |
302964-02-9 |
Dasatinib |
Commercial |
|
(E) -N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide |
863127-76-8 |
Dasatinib |
Commercial |
|
2-Amino-N-(2-chloro-6- |
302964-24-5 |
Dasatinib |
Pilot Scale |
|
N-(2-Chloro-6-methylphenyl)-2- |
302964-08-5 |
Dasatinib |
Lab Scale |
|
4,6-dichloro-2- |
1780-26-3 |
Dasatinib |
Commercial |
|
N-Boc-D-phenyl glycinol |
102089-74-7 |
Elagolix |
Pilot Scale |
|
2,3-dihydrobenzo[b][1,4] |
29668-44-8 |
Eliglustat |
Commercial |
|
S(+)-2-Phenylglycinol |
20989-17-7 |
Eliglustat |
Commercial |
|
2, 4-Difluoro-5-Iodobenzoic acid |
161531-51-7 |
Elvitegravir |
Commerical |
|
Ethyl 7-fluoro-1,4-dihydro-1-((S)-1- |
697762-60-0 |
Elvitegravir |
Commerical |
|
3-(N-Methyl-N-Pentyl amino)propionic acid HCl |
625120-81-2 |
Ibandronate |
Commercial |
|
N-(5-Amino-2-methylphenyl)-4-( |
152460-10-1 |
Imatinib |
Commercial |
|
4-oxo-1,4-dihydroquinoline-3- |
13721-01-2 |
Ivacaftor |
Commercial |
|
Ethyl 4-Oxo-1,4-dihydroquinoline-3- |
52980-28-6 |
Ivacaftor |
Commercial |
|
5-Amino-2,4-ditert-butylphenol |
873055-58-4 |
Ivacaftor |
Lab Scale |
|
2-chloromorpholinoehtan-1-one |
1440-61-5 |
Lesinurad |
Pilot Scale |
|
Ethyl 2-(2-aminothiazol-4-yl)acetate |
53266-94-7 |
Mirabegron |
Commercial |
|
2-(2-Aminothiazol-4-yl)acetic acid |
29676-71-9 |
Mirabegron |
Commercial |
|
2-(2-Aminothiazol-4-yl)acetic acid hydrochloride |
66659-20-9 |
Mirabegron |
Commercial |
|
2-(4-nitrophenyl)ethanamine hydrochloride |
29968-78-3 |
Mirabegron |
Commercial |
|
(R)-2-(4-nitrophenethylamino)- |
521284-21-9 |
Mirabegron |
lab Scale |
|
(R)-4-nitro phenethylamino-(2- |
223673-35-6 |
Mirabegron |
lab Scale |
|
(R)-2-((4-Aminophenethyl) |
391901-45-5 |
Mirabegron |
Pilot Scale |
|
(R)-2-(4-aminophenethylamino)- |
521284-22-0 |
Mirabegron |
Commercial |
|
1-(3-Chloropropyl)-1,3- |
62780-89-6 |
Oxatomide |
Lab scale |
|
3-[(Dimethylamino)methyl]-1,2, |
119812-29-2 |
Ondansetron |
Commercial |
|
4-(6-Fluoro-1,2-benzisoxazole- |
84163-13-3 |
Palperidone/Risperidone |
Commercial |
|
3-(Benzyloxy)pyridine-2-amine |
24016-03-3 |
Paliperidone |
Commercial |
|
3-(2-Chloroethyl)-9-Hydroxy-2- |
849727-62-4 |
Palperidone |
Lab scale |
|
11-(piperazine-1-yl)dienzo[b, |
11974-74-4 |
Quetiapine |
Commercial |
|
2-Benzyl acrylic acid |
5669-19-2 |
Racecadotril |
Commercial |
|
Benzyl glycinate p-toluene sulfonate |
1738-76-7 |
Racecadotril |
Commercial |
|
R)-4-chloro-N-(2-hydroxy-3-(4- |
721401-53-2 |
Rivaroxaban |
Under development |
|
4-Oxo-4-[3-(trifluoromethyl)- |
764667-65-4 |
Sitagliptin |
Commercial |
|
(2Z)-4-Oxo-4-[3-( |
767340-03-4 |
Sitagliptin |
lab Scale |
|
3-Quinuclidinone hydrochloride |
1193-65-3 |
Solifenacin |
Commercial |
PHOSPHOLIPID FORMULATIONS
For Menopause, Psoriasis, Memory, Liver, Stress Management
INTERMEDIATES
7 PACA / APRA, 6 APA, PEN G CILASTATIN ACID